News + Filings IR Vault
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results CC transcript Inv. presentation Appointed director Director departure Credit agrmnt [a] Asset disposition Acq. announced Appointed CFO Consulting agrmnt Auditor change Notes underwriting agrmnt Director comp. Employment agrmnt Dividend declared Appointed COO Filed Chapter 11 Monthly dividend Preliminary results Accel. buyback Cert. of designation Acq. completed Monthly oper. report Merger agrmnt [a] Quarterly results presentation Class action filed CFO resigned Departure of a VP SSS news release Asset acq. complete Letter to company Buyback announced Bonus plan approved Upcoming conference date Notes have priced Coll. bargaining agrmnt 10-Q late filing RE purchase Amended bylaws New credit facility
|
All Companies
|
Create: Portfolio | Alert |
All | News | Filings
Date Filed | Symbol | Type | Description |
05/02/2022 |
******
|
8-K
| Includes a letter to the company / board of directors |
12/15/2021 |
NOVS
|
8-K
| Quarterly results |
08/03/2021 |
******
|
8-K
| Quarterly results |
03/26/2020 |
DIOD
|
8-K
| Quarterly results |
10/03/2019 |
AP
|
8-K
| Quarterly results |
11/28/2017 |
CDMO
|
8-K
| Includes a letter to the company / board of directors
Docs:
|
"Settlement Agreement, by and among Peregrine Pharmaceuticals, Inc., Ronin Trading, LLC, Ronin Capital, LLC, SWIM Partners LP, SW Investment Management LLC, John S. Stafford, III, Stephen White and Roger Farley",
"New Directors" |
|
05/03/2016 |
NAVB
|
8-K
| Includes a letter to the company / board of directors |
12/13/2012 |
EQC
|
8-K
| Includes a letter to the company / board of directors |
06/28/2011 |
CHBT
|
8-K
| Includes a letter to the company / board of directors |
04/11/2011 |
SBAY
|
8-K/A
| Includes a letter to the company / board of directors |
04/07/2011 |
SBAY
|
8-K
| Includes a letter to the company / board of directors |
08/06/2010 |
SUI
|
8-K
| Form 8-K - Current report |
08/06/2010 |
EHSK
|
8-K
| Form 8-K - Current report |
04/06/2010 |
MWWC
|
8-K
| Entered into consulting agreement, Includes a letter to the company / board of directors |
08/10/2009 |
NTFL
|
8-K
| Form 8-K - Current report |
04/08/2009 |
AREM
|
8-K/A
| Form 8-K/A -- Current report [amend] |
05/19/2008 |
OEHL
|
8-K
| Includes a letter to the company / board of directors |
04/11/2008 |
BGP
|
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
08/06/2007 |
TEWI
|
8-K/A
| Includes a letter to the company / board of directors |
03/06/2007 |
TOPP
|
8-K/A
| Includes a letter to the company / board of directors |
11/13/2006 |
CLRT
|
8-K
| Other Events, Financial Statements and Exhibits |
08/28/2006 |
URGP
|
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and... |
04/03/2006 |
NATR
|
8-K
| Form 8-K - Current report |
10/07/2005 |
IPEX
|
8-K/A
| Resignation/termination of a director, Includes a letter to the company / board of directors
Docs:
|
"Letter from Edward Sullivan to the Company, dated October 4, 2005. Item 5.02 - Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers. Resignation of Director On September 7, 2005, Edward Sullivan resigned as a member of the Board of Directors of the Company after a request of the Company for him to do so in order to reconstitute the Board with independent Board members. At the time of his resignation, Mr. Sullivan was Chairman of the Company's Code of Ethics Committee and a member of the Company's Stock Option Plan Committee. Mr. Sullivan also served as a member of the Audit Committee during his employment with the Company. On September 27, 2005, the Company filed the Original Form 8-K to report this information, and, as required by law, pro..." |
|
05/06/2004 |
ENTU
|
8-K
| Includes a letter to the company / board of directors |
07/25/2003 |
******
|
8-K
| Includes a letter to the company / board of directors
Docs:
|
"IGEN CAUTIONARY NOTE ON FORWARD-LOOKING STATEMENTS",
"Agreement and Plan of Merger, among Roche Holding Ltd, 66 Acquisition Corporation II, IGEN International, Inc. and IGEN Integrated Healthcare, LLC",
"Restructuring Agreement, between IGEN International, Inc. and IGEN Integrated Healthcare, LLC",
"Post-Closing Covenants Agreement, among Roche Holding Ltd, IGEN International, Inc. and IGEN Integrated Healthcare, LLC",
"Tax Allocation Agreement, among Roche Holding Ltd, 66 Acquisition Corporation II, IGEN International, Inc. and IGEN Integrated Healthcare, LLC",
"Ongoing Litigation Agreement, among IGEN International, Inc., Roche Diagnostics GmbH and Roche Diagnostics Corporation",
"Release and Agreement, between IGEN International, Inc., IGEN Integrated Healthcare, LLC and each company",
"Global Consent and Agreement, among Roche Holding Ltd, IGEN International, Inc., IGEN Integrated Healthcare, LLC, Meso Scale Diagnostics, LLC., Meso Scale Technologies, LLC., Jacob Wohlstadter and JW Consulting Services L.L.C",
"Letter Agreement, among Meso Scale Diagnostics, LLC., Meso Scale Technologies, LLC., JW Consulting Services, L.L.C., Jacob N. Wohlstadter and IGEN International, Inc",
"Letter Agreement, between Samuel J. Wohlstadter and IGEN Integrated Healthcare, LLC" |
|
02/18/2003 |
TENF
|
8-K
| Includes a letter to the company / board of directors |
09/20/2001 |
******
|
8-K
| Includes a letter to the company / board of directors |
11/08/2000 |
******
|
8-K
| Includes a letter to the company / board of directors |
09/27/2000 |
IFF
|
8-K
| Form 8-K - Current report |
12/11/1998 |
******
|
8-K
| Includes a letter to the company / board of directors |
|
|